U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07424261) titled 'NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care' on Feb. 13.
Brief Summary: VIOLET is a prospective, single-arm, multi-centre, non-interventional study (NIS) evaluating real-world clinical and patient-reported outcome (PRO) data in adult patients who are initiated on subcutaneous anifrolumab treatment of systemic lupus erythematosus (SLE) in line with the applicable european summary of product characteristics (SmPC) and neither having used anifrolumab subcutaneous (SC) or intravenous (IV) before.
Study Start Date: March 31
Study Type: OBSERVATIONAL
Condition:
Lupus Erythemato...